Effect of coadministration of enriched Korean red ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A randomized controlled trial
ConclusionCoadministration of Rg3-KRG + AG is an effective addon for improving BP along with attaining favorable cardiometabolic outcomes in individuals with type 2 diabetes. Ginseng derivatives may offer clinical utility when included in the polypharmacy and lifestyle treatment of diabetes.Clinical trial registrationClinicaltrials.gov identifier, NCT01578837;
Source: Journal of Ginseng Research - Category: Complementary Medicine Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Complementary Medicine | Diabetes | Diabetes Type 2 | Endocrinology | Ginseng | Heart | Hypertension | Wheat